I'll research this company to verify its profile.
3Shape A/S
Overview. 3Shape A/S is a Danish digital-dentistry company founded in 2000 by Tais Clausen and Nikolaj Deichmann, with headquarters in Copenhagen (registered address Holmens Kanal 7, 1060 Copenhagen). It is privately held: the two founders remain majority owners, and private-equity firm EQT acquired a roughly 20 percent minority stake in December 2021 (closed Q1 2022). The company reports more than 2,200 employees across 28–29 countries and 2024 group revenue of about DKK 3.3 billion (roughly USD 500 million). Records for the legal entity 3Shape A/S also list a smaller employee count (~475) for that specific Danish registration.
Products / operations. 3Shape develops and sells 3D scanning hardware and CAD/CAM software for dental practices, dental labs, and (historically) hearing-aid manufacturers. Major lines include the TRIOS intraoral scanner family (TRIOS 3, 5, Core, and TRIOS 6), lab scanners such as the D200 and F8, cone-beam CT (X1), restorative and orthodontic design/CAM software, and the 3Shape Unite platform for connecting practices, labs, and treatment partners. It is an operating company with real hardware and software products, not a licensor or shell.
Patent-litigation posture. The tracked data show a single case in which 3Shape appears, and it is as a defendant (1 defendant, 0 plaintiff). That is consistent with an operating company being sued rather than a party asserting an acquired portfolio. The venue is the U.S. District Court for the District of Delaware — a common patent forum but not a plaintiff-favorable Texas venue like the Eastern District of Texas.
Notable case. The sole tracked matter is Align Technology, Inc. v. 3Shape A/S et al., filed November 14, 2017, in Delaware. Align Technology is the maker of the Invisalign clear-aligner system and a direct competitor in digital dental scanning and orthodontics; the suit reflects the long-running global patent conflict between the two companies over intraoral scanning and digital dentistry technology. No merits findings are asserted here.